Invention Grant
- Patent Title: Therapeutic inhibitory compounds
-
Application No.: US15199785Application Date: 2016-06-30
-
Publication No.: US10023557B2Publication Date: 2018-07-17
- Inventor: Andrew McDonald , Shawn Qian
- Applicant: LifeSci Pharmaceuticals, Inc.
- Applicant Address: BB St. Michael
- Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee Address: BB St. Michael
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; C07D471/04 ; C07D487/04
Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
Public/Granted literature
- US20170029406A1 THERAPEUTIC INHIBITORY COMPOUNDS Public/Granted day:2017-02-02
Information query
